Completed Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies NCT01823198 Conditions Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, +36 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
Active, Not Recruiting Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia NCT00392353 Conditions Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +27 more Locations University of Chicago Comprehensive Cancer Center — Chicago, Illinois, United States University of Maryland/Greenebaum Cancer Center — Baltimore, Maryland, United States North Shore University Hospital — Manhasset, New York, United States Mount Sinai Hospital — New York, United States View more locations Show fewer locations Loading locations... View Trial Details
